Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
Checking In: Are Your State Legislators Concentrating on Drug-Price…
Price transparency is such a hot topic today that it is oftentimes hard to keep up with the different state legislatures that are…
New PhRMA Website Tackles Pharmaceutical Cost and Coverage
On January 24, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched a new website,…
PhRMA Releases Report on Financial Flow in Pharmaceutical Industry
In late November, the Pharmaceutical Research and Manufacturers Association (PhRMA) released a new report examining how money…
ICER Expanding Probe
A nonprofit group, the Institute for Clinical and Economic Review (ICER), recently received a three-year $13.9 million grant from…
Sharing Negotiated Discounts Could Save Patients Money
Providing access to discounted medicine prices at the point of sale (i.e., at the pharmacy directly) could save certain…
New Research Published on Generic Competition
As the FDA looks to boost generic competition, a new working paper published by the National Bureau of Economic Research…
California Enacts Legislation on Reporting of Prescription Drug Costs
California’s Senate and Assembly have both passed legislation on publishing prescription drug prices (SB-17) and presented the…
Maryland Law to Restrict Generic Drug Price Increases
Late last week, Maryland Governor Larry Hogan allowed a law targeted at preventing generic drug prices from increasing by too…
MedPAC Approves Part B Payment Recommendations
In early April, during the first session of the Medicare Payment Advisory Commission’s (MedPAC’s) public meeting, the Commission…
New Analysis Shows Out-of-Pocket Spending Based on List Price
New analysis from Amundsen Consulting, a division of QuintilesIMS, shows that more than half of commercially insured patients’…